30 March 2024, Volume 34 Issue 3
Cover and contents

2024 Issue 3 Cover

Abstract ( 58) PDF (5586KB) ( 103 )

Contents of Issue 3, 2024

2024, 34 (3): 2-2.

Abstract ( 17) PDF (10552KB) ( 37 )

Specialist' Commentary

Progress and prospects of gastric cancer treatment in the 21st century

XU Yonghu, XU Dazhi

2024, 34 (3): 239-249. doi: 10.19401/j.cnki.1007-3639.2024.03.001

Abstract ( 67) PDF (1127KB) ( 154 ) HTML ( 19 )

New progress and development trend of surgical treatment for gastric cancer

WANG Xuefei, ZHOU Peng, TANG Zhaoqing

2024, 34 (3): 250-258. doi: 10.19401/j.cnki.1007-3639.2024.03.002

Abstract ( 53) PDF (1107KB) ( 167 ) HTML ( 7 )

Application and challenge of immunotherapy in perioperative therapy of gastric cancer

XUE Chi, GAO Peng, ZHU Zhi, WANG Zhenning

2024, 34 (3): 259-267. doi: 10.19401/j.cnki.1007-3639.2024.03.003

Abstract ( 27) PDF (1162KB) ( 164 ) HTML ( 4 )

Specialist' Article

Survival analysis of 6 737 surgically resected gastric cancer cases in China from a large single institution hospital-based cancer registry database

SHEN Jie, WANG Jiangli, WANG Zezhou, MO Miao, ZHOU Changming, YUAN Jing, XU Dazhi, ZHENG Ying

2024, 34 (3): 268-277. doi: 10.19401/j.cnki.1007-3639.2024.03.004

Abstract ( 25) PDF (1161KB) ( 136 ) HTML ( 10 )

Article

Application value of combined coagulation function indicators in monitoring hypercoagulable state of patients with colorectal cancer after chemotherapy

LU Yue, LU Renquan, ZHANG Jie, ZHENG Hui

2024, 34 (3): 278-285. doi: 10.19401/j.cnki.1007-3639.2024.03.005

Abstract ( 38) PDF (1178KB) ( 139 ) HTML ( 7 )

Analysis of effects of trastuzumab assisted modified DOF fortnightly regimen on serum tumor markers and survival rate in patients with cisplatin-resistant gastric cancer

LI Jing, ZHENG Lei, GAO Yu

2024, 34 (3): 286-292. doi: 10.19401/j.cnki.1007-3639.2024.03.006

Abstract ( 22) PDF (975KB) ( 127 ) HTML ( 2 )

Surgical margin and efficacy evaluation of barrier resection for soft tissue sarcoma of extremities in 72 cases

QU Guolun, ZHANG Ruming, CHEN Yong, QU Xinglong, ZHANG Hongqiang, WANG Hongbo, WANG Kangwei, PENG Shuai

2024, 34 (3): 293-298. doi: 10.19401/j.cnki.1007-3639.2024.03.007

Abstract ( 22) PDF (986KB) ( 109 ) HTML ( 3 )

Review

Research progress of CCR8 in tumor immunotherapy

CHEN Yifan, LI Ting, WANG Biyun

2024, 34 (3): 299-305. doi: 10.19401/j.cnki.1007-3639.2024.03.008

Abstract ( 57) PDF (1072KB) ( 94 ) HTML ( 6 )

Research progress on H-E stained whole slide image analysis by artificial intelligence in lung cancer

JIANG Mengqi, HAN Yuchen, FU Xiaolong

2024, 34 (3): 306-315. doi: 10.19401/j.cnki.1007-3639.2024.03.009

Abstract ( 33) PDF (1151KB) ( 98 ) HTML ( 2 )

Guideline and Concensus

Expert consensus on clinical applications of ovarian function suppression for Chinese women with early breast cancer (2024 edition)

Committee of Breast Cancer Society, China Anti-Cancer Association

2024, 34 (3): 316-333. doi: 10.19401/j.cnki.1007-3639.2024.03.010

Abstract ( 62) PDF (2312KB) ( 106 ) HTML ( 9 )

中国癌症杂志
    Database Indexing
  • A Guide to the Core Journals of China
  • Chinese Science Citation Database (CSCD)
  • China National Knowledge Infrastructure (CNKI)
  • Chinese Sci-tech Paper and Citation Database (CSTPCD)
  • Outsanding S&T Journals of China (2020) (F5000)
  • World Journal Clout Index (WJCI) Report of Scientific and Technological Periodicals (2021)
  • SCOPUS
  • EMBASE
  • DOAJ
  • Chemical Abstracts (CA)
  • Japan Science and Technology Database (JST)
  • The Western Pacific Region Index Medicus (WPRIM)
  • EBSCO
  • Index of Copernicus International (ICI)

Competent Authorities

 The Ministry of Education of the People’s Republic of China

Sponsored by

 Fudan University Shanghai Cancer Center

Edited by

 Editorial Board of China Oncology

Editor-in-Chief

 SHAO Zhimin

Honorary Editor-in-Chief

 TANG Zhaoyou, CAO Shilong, SHEN Zhenzhou

Printed by

 Shanghai Ouyang Printing Co., Ltd.

WeChat